CVS raises 2021 profit view as COVID-19 vaccines, tests drive retail strength

This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEI0A0LM_L.jpg

(Reuters) – CVS Health Corp (NYSE:CVS) on Tuesday raised its adjusted earnings forecast for 2021, citing strong retail sales helped by higher demand for COVID-19 vaccines as well as over-the-counter testing in November and December.

The company, best known for its chain of drugstores, raised its forecast for 2021 adjusted profit per share to a range of $8.33 to $8.38, up from at least $8.00 previously.

Add Comment